Protective effects of hydroxyethyl starch 130/0.4 against myocardial ischemia/reperfusion injury in rats

Chinese Medical Journal

Volumn 124, Issue 2, 2011, Pages 291-297

  Sun, Hai Jing ^a   Li, Hao ^a   Zou, Zui ^a   Shi, Xue Yin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Hydroxyethyl starch; Myocardial ischemia; NF B; Reperfusion injury

Indexed keywords

ALBUMIN; HETASTARCH; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MYELOPEROXIDASE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; REPERFUSION INJURY;

ANIMALS; HEMODYNAMICS; HETASTARCH; INTERLEUKIN-1BETA; MALE; NF-KAPPA B; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79551696967     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.02.026     Document Type: Article

References (36)

1. Handrigan MT, Burns AR, Donnachie EM, Bowden RA. Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration. Shock 2005; 24: 434-439.
2. Lang JD Jr, Figueroa M, Chumley P, Aslan M, Hurt J, Tarpey MM, et al. Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium. Anesthesiology 2004; 100: 51-58.
3. Tian J, Lin X, Zhou W, Xu J. Hydroxyethyl starch inhibits nf-kappab activation and prevents the expression of inflammatory mediators in endotoxic rats. Ann Clin Lab Sci 2003; 33: 451-458.
4. Lv R, Zhou W, Zhang LD, Xu JG. Effects of hydroxyethyl starch on hepatic production of cytokines and activation of transcription factors in lipopolysaccharide-administered rats. Acta Anaesthesiol Scand 2005; 49: 635-642.
5. Dieterich HJ, Weissmuller T, Rosenberger P, Eltzschig HK. Effect of hydroxyethyl starch on vascular leak syndrome and neutrophil accumulation during hypoxia. Crit Care Med 2006; 34: 1775-1782.
6. Tian YK, Wu Z. Effect of hemodilution with 6% hydroxyethyl starch (200/0.5) on expression of intercellular adhesion molecule-1 after global cerebral ischemia-reperfusion in rats. Chin J Anesthesiol (Chin) 2002; 22: 734-736.
7. Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol 2010; Epub ahead of print.
8. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of hes 130/0.4 (voluven(r)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: A prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 2008; 25: 986-994.
9. Muralidhar K, Garg R, Mohanty S, Banakal S. Influence of colloid infusion on coagulation during off-pump coronary artery bypass grafting. Indian J Anaesth 2010; 54: 147-153.
10. Guo X, Xu Z, Ren H, Luo A, Huang Y, Ye T. Effect of volume replacement with hydroxyethyl starch solution on splanchnic oxygenation in patients undergoing cytoreductive surgery for ovarian cancer. Chin Med J 2003; 116: 996-1000.
11. Catre D, Viana JS, Cabrita AM, Oliveira M, Felizes A, Lopes MF. Hydroxyethyl starch 130/0.4 attenuates early hepatic damage in ischemia/reperfusion injury. Can J Anaesth 2010; 57: 439-445.
12. Tian J, Xu JG. Effect of hydroxyethyl starch on lung capillary permeability in endotoxemic rat. Chin J Anesthesiol (Chin) 2004; 24: 122-125.
13. Tian J, Lin X, Xu JG. Effects of hydroxyethyl starch on neutrophil activation in endotoxic rats and possible mechanisms. J Nanjing University (Chin) 2004; 40: 517-522.
14. Wang C, Weihrauch D, Schwabe DA, Bienengraeber M, Warltier DC, Kersten JR, et al. Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats. Anesth Analg 2006; 103: 281-288.
15. Barone FC, Hillegass LM, Price WJ, White RF, Lee EV, Feuerstein GZ, et al. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification. J Neurosci Res 1991; 29: 336-345.
16. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and kc. Hepatology 1998; 27: 1172-1177.
17. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31-47.
18. Yao Y, Yu Y, Wu Y, Shi Z, Sheng Z. The role of gut as a cytokine-generating organ in remote organ dysfunction after intestinal ischemia and reperfusion. Chin Med J 1998; 111: 514-518.
19. Yu CP, Wang Q, Fang XM. Effect of 6% hydroxyethyl starch on the plasma interleukin-1 levels in septic rat. Zhejiang Med J 2004; 26: 28-29.
20. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Schildberg FW, Menger MD. Hydroxyethyl starch (130 kd), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology 2002; 97: 460-470.
21. Tian J, Lin X, Guan R, Xu JG. The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth Analg 2004; 98: 768-774.
22. Lv R, Zhou W, Chu C, Xu J. Mechanism of the effect of hydroxyethyl starch on reducing pulmonary capillary permeability in a rat model of sepsis. Ann Clin Lab Sci 2005; 35: 174-183.
23. Lv R, Zhou ZQ, Wu HW, Jin Y, Zhou W, Xu JG. Hydroxyethyl starch exhibits antiinflammatory effects in the intestines of endotoxemic rats. Anesth Analg 2006; 103: 149-155.
24. Feng X, Yan W, Liu X, Duan M, Zhang X, Xu J. Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and nf-kappab activation in clp-induced sepsis in rats. J Surg Res 2006; 135: 129-136.
25. Zikria BA, Subbarao C, Oz MC, Popilkis SJ, Sachdev R, Chauhan P, et al. Hydroxyethyl starch macromolecules reduce myocardial reperfusion injury. Arch Surg 1990; 125: 930-934.
26. Wisselink W, Patetsios P, Panetta TF, Ramirez JA, Rodino W, Kirwin JD, et al. Medium molecular weight pentastarch reduces reperfusion injury by decreasing capillary leak in an animal model of spinal cord ischemia. J Vasc Surg 1998; 27: 109-116.
27. Chandrasekar B, Streitman JE, Colston JT, Freeman GL. Inhibition of nuclear factor kappa b attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. Biochim Biophys Acta 1998; 1406: 91-106.
28. Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-kappab, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999; 45: 7-17.
29. Wang X, Barone FC, Aiyar NV, Feuerstein GZ. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 1997; 28: 155-161.
30. Fan H, Sun B, Gu Q, Lafond-Walker A, Cao S, Becker LC. Oxygen radicals trigger activation of NF-kappab and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol 2002; 282: H1778-H1786.
31. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621-1628.
32. Bardales RH, Hailey LS, Xie SS, Schaefer RF, Hsu SM. In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 1996; 149: 821-829.
33. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M. Nf-kappab is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999; 5: 554-559.
34. Baldwin AS Jr. The Nf-kappa B and I Kappa B proteins: New discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
35. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding, and activation. Mol Cell 2002; 9: 423-432.
36. Wu XW, Teng ZY, Jiang LH, Fan Y, Zhang YH, Li XR, et al. Human thioredoxin exerts cardioprotective effect and attenuates reperfusion injury in rats partially via inhibiting apoptosis. Chin Med J 2008; 121: 819-826.